Gaurav Shah - 10 Apr 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Issuer symbol
RCKT
Transactions as of
10 Apr 2025
Net transactions value
+$101,600
Form type
4
Filing time
14 Apr 2025, 18:57:31 UTC
Previous filing
25 Feb 2025
Next filing
20 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Purchase $101,600 +20,000 +2.6% $5.08 792,680 10 Apr 2025 Direct
holding RCKT Common Stock 207,897 10 Apr 2025 By Spouse
holding RCKT Common Stock 198,341 10 Apr 2025 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.